Stay updated on Duvelisib in Refractory Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Duvelisib in Refractory Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page’s revision label updated to v3.5.5, signaling a backend or CMS update rather than a change to the study details or visible content.
    Difference
    0.0%
    Check dated 2026-06-08T15:50:15.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4, indicating a behind-the-scenes update to the page or system. The study content and user-facing information appear unchanged.
    Difference
    0.0%
    Check dated 2026-05-18T03:53:29.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Updates the site footer revision/version label from v3.5.0 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-26T15:17:39.000Z thumbnail image
  6. Check
    84 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 on the page. This update does not modify the study content or details.
    Difference
    0.0%
    Check dated 2026-03-21T07:56:18.000Z thumbnail image
  7. Check
    98 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T20:13:07.000Z thumbnail image
  8. Check
    120 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing the previous v3.4.1. No study data or key page content appear to be affected.
    Difference
    0.0%
    Check dated 2026-02-13T12:26:05.000Z thumbnail image

Stay in the know with updates to Duvelisib in Refractory Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Duvelisib in Refractory Lymphoma Clinical Trial page.